How to Cite



Stroke is a leading cause of disability and death. In more than 30% of
patients a disabling stroke is preceded by milder transient symptoms.
The risk of stroke in patients with transient ischemic attacks (TIAs)
and minor stroke may be very high in the initial days following the
symptoms. Identification of such patients and appropriate treatment
can lead to a significant decrease in the risk of subsequent stroke. This
review will focus on two important issues; the impact of introduction of
newer technology on identification of high-risk patients and the recent
advances in antithrombotic therapy in stroke prevention in patients
with TIAs and minor stroke. Appropriate use of imaging and cardiac
rhythm monitoring allow for identification of high risk patients and the
use of dual antiplatelet therapy early, following an acute TIA or minor
stroke, significantly reduces the risk of recurrence.
Key Words: transient ischemic attacks (TIAs), Stroke, Ischemic Stroke.



Giles MF, Rothwell PM. Risk of stroke

early after transient ischemic attack: A

systematic review and meta-analysis.

Lancet Neurol, 2007. 6(12): p. 1063-72.

KleindorferD, Panagos P, Pancioli A,

Khoury J, Kissela B, Woo D, et al., Incidence

and short-term prognosis of transient

ischemic attack in a population-based

study. Stroke 2005; 36(4): 720-3.

Rothwell PM, Giles MF, Chandratheva A,

Marquardt L, Geraghty O, Redgrave JN, et

al. Effect of urgent treatment of transient

ischemic attack and minor stroke on early

recurrent stroke (EXPRESS study): A

prospective population-based sequential

comparison. Lancet 2007; 370(9596):


Rao SV, Ohman EM, Granger CB, Armstrong

PW, Gibler WB, Christenson RH,

et al., Prognostic value of isolated troponin

elevation across the spectrum of chest

pain syndromes. Am J Cardiol 2003;

(8): 936-40.

Kennedy J, Hill MD, Ryckborst KJ, Eliasziw

M, Demchuk AM, Buchan AM; FASTER

Investigators. Fast assessment of stroke

and transient ischemic attack to prevent

early recurrence (FASTER): a randomised

controlled pilot trial. Lancet Neurol 2007;

(11): 961-9.

Johnston SC, Gress DR, Browner WS, Sidney

S. Short-term prognosis after emergency-

department diagnosis of transient

ischemic attack. JAMA 2000; 284: 2901-6.

Dean N, Shuaib A. Transient ischemic

attacks: unstable, treatable, neglected.

Lancet 2007; 370(9596): 1398-400.

Kang DW, Latour LL, Chalela JA, Dambrosia

JA, Warach S. Early and late recurrence

of ischemic lesion on MRI: evidence for a

prolonged stroke-prone state? Neurology

; 63(12): 2261-5.

Rothwell PM, Giles MF, Flossmann E,

Lovelock CE, Redgrave JN, Warlow CP,

et al., A simple score (ABCD) to identify

individuals at high early risk of stroke after

transient ischemic attack. Lancet 2005;

(9479): 29-36.

Coutts SB, Simon JE, Eliasziw M, Sohn

CH, Hill MD, Barber PA, et al., Triaging

transient ischemic attack and minor stroke

patients using acute magnetic resonance

imaging. Ann Neurol 2005; 57(6): 848-54.

Fuster V, Fayad ZA, Badimon JJ. Acute

coronary syndromes: biology. Lancet

; 353 Suppl 2: SII5-9.

CURE Investigators, Effects of clopidogrel

in addition to aspirin in patients with acute

coronary syndromes without ST-segment

elevation. N Engl J Med 200; 345: 494-502.

Wang Y, Zhao X, Liu L, Wang D, Wang

C, et al. Clopidogrel with aspirin in acute

minor stroke and transient ischemic attack

(CHANCE study). New E J Med 2013;

: 11-9.

Ovbiagele, B. Antiplatelet therapy in

management of transient ischemic attack:

overview and evidence-based rationale. J

Emerg Med 2008; 34(4): 389-96.

Kernan WN, Ovbiagele B, Black HR,

Bravata DM, Chimowitz MI, Ezekowitz

MD, et al. Guidelines for the prevention

of stroke in patients with stroke and

transient ischemic attack: a guideline for

healthcare professionals from the American

Heart Association/American Stroke

Association. Stroke. 2014 May 1 [Epub

ahead of print]. Available at: https://stroke.


Antithrombotic therapy and prevention

of thrombosis. American College of Physicians

evidence-based guidelines. Chest

; 142: supplement 1.

Lavallee PC, Meseguer E, Abboud H,

Cabrejo L, Olivot JM, Simon O, et al.,

A transient ischemic attack clinic with

round-the-clock access (SOS-TIA): feasibility

and effects. Lancet Neurol 2007;

(11): 953-60.

Antiplatelet Trialists’ Collaboration, Collaborative

overview of randomised trials

of antiplatelet therapy-I: Prevention of

death, myocardial infarction, and stroke by

prolonged antiplatelet therapy in various

categories of patients. Br Med J 1994;

(6921): 81-106.

Sharis PJ, Cannon CP, Loscalzo J. The

antiplatelet effects of ticlopidine and

clopidogrel. Ann Intern Med 1998; 129(5):


CAPRIE Steering Committee, A randomised,

blinded, trial of clopidogrel

versus aspirin in patients at risk of ischemic

events (CAPRIE). Lancet 1996; 348(9038):

-39. 103.

Abuzahra, M, Pillai M, Caldera A, Hartley

WB, Gonzalez R, Bobek J, et al., Comparison

of higher clopidogrel loading and maintenance

dose to standard dose on platelet

function and outcomes after percutaneous

coronary intervention using drug-eluting

stents. Am J Cardiol 2008; 102(4): 401-3.

Jauhar, R, Bergman G, Savino S, Deutsch

E, Shaknovich A, Parikh M, et al., Effectiveness

of aspirin and clopidogrel combination

therapy in coronary stenting. Am J

Cardiol 1999; 84(6): 726-8, A8.

Bhatt, DL, Fox KA, Hacke W, Berger PB,

Black HR, Boden WE, et al., Clopidogrel

and Aspirin versus Aspirin Alone for the

Prevention of Atherothrombotic Events.

N Engl J Med, 2006; 354(16): 1706-17.

Platelet-Oriented Inhibition in New TIA

and Minor Ischemic Stroke (POINT) Trial. Identifier: NCT00991029

[Cited on September 20, 2014]: Available

from URL:


SOCRATES -Acute Stroke Or Transient

IsChaemic Attack TReated With Aspirin or

Ticagrelor and Patient OutcomES]. ClinicalTrials.

gov Identifier: NCT01994720

[Cited on September 20, 2014]: Available

from URL:


Gladstone DJ, Spring M, Dorian P, Panzov

V, Thorpe KE, Hall J, et al for the EMBRACE

Investigators and Coordinators.

Atrial Fibrillation in Cryptogenic Stroke.

New Eng J Med 2014; 370: 2467-77.

Sanna T, Diener HC, Passman RS, Di

Lazzaro V, Bernstein RA, Morillo CA, et

al. Cryptogenic stroke and underlying

atrial fibrillation. New Eng J Med 2014;

: 2478-86.

Mouradian MS, Rodgers J, Kashmere J,

Jickling G, McCombe J, Emery DJ, et al.

Can t-PA be administered to the wrong

patient? Two Patients with Somatoform

Disorder, Can J Neurol Sci 2004; 31:


Johnston SC, Rothwell PM, Nguyen-Huynh

MN, Giles MF, Elkins JS, Bernstein AL, et

al. Validation and refinement of scores

to predict very early stroke risk after

transient ischemic attack. Lancet 2007;

(9558): 283-92.

Asdaghi N, Hill MD, Coulter JI, Butcher

KS, Modi J, Qazi A, et al. Perfusion MR

predicts outcome in high-risk TIA and

minor stroke. A derivation and validation

study. Stroke 2013; 44: 2486-92.

Ibrahim Y, Basir G, Ghrooda E, Mohammad

A, Khan N, Dobrowolski P, et al. Prolonged

monitoring of cardiac rhythm for

detection of atrial fibrillation after cerebral

ischemic events (PEAACE) study. Neurology

; 82 (10): Supplement P1.130.

Hart R, Deiner C, Coutts SB, Easton JD,

Granger CB, O’Donnell MJ, et al. Embolic

strokes of undetermined source: the case

for a new clinical construct. Lancet Neurol

; 13(4): 429-38.

Bell AD, Roussin A, Cartier R, Chan WS,

Douketis JD, Gupta A, et al. The use of

antiplatelet therapy in the outpatient

setting: Canadian Cardiovascular Society

Guidelines Executive Summary. Can J

Cardiol 2011; 27(2): 208-21.

Coutts SB, Eliasziw M, Hill MD, Scott JN,

Subramaniam S, Buchan AM, et al. An

improved scoring system for identifying

patients at high early risk of stroke and

functional impairment after an acute transient

ischemic attack or minor stroke. Int

J Stroke 2008; 3(1): 3-10.

Diener HC, Bogousslavsky J, Brass LM,

Cimminiello C, Csiba L, Kaste M, Leys D,

et al., Aspirin and clopidogrel compared

with clopidogrel alone after recent ischemic

stroke or transient ischemic attack in

high-risk patients (MATCH): randomised,

double-blind, placebo-controlled trial.

Lancet 2004; 364(9431): 331-7.

Markus HS, Droste DW, Kaps M, Larrue V,

Lees KR, Siebler M, et al., Dual antiplatelet

therapy with clopidogrel and aspirin in

symptomatic carotid stenosis evaluated

using doppler embolic signal detection: the

Clopidogrel and Aspirin for Reduction of

Emboli in Symptomatic Carotid Stenosis

(CARESS) trial. Circulation 2005; 111(17):


Work published in KMUJ is licensed under a

 Creative Commons Attribution-NonCommercial 2.0 Generic License.

Creative Commons License

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.